Since LS1 exhibits lower immune activity, while LS2 and LS3 show stronger immune cell infiltration and higher levels of immune checkpoints, we classified LS2 and LS3 as “hot tumors” and LS1 as a “cold tumor”. This evidence concerns the gene SERPIND1 and neoplasm.